| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 32.397 | 35.681 | 41.813 | 18.379 | 0 | 12.957 | 17.816 | 5.272 | 0 | 8.045 |
| Total Income - EUR | 32.397 | 35.681 | 42.805 | 18.379 | 0 | 12.957 | 17.816 | 5.272 | 0 | 8.045 |
| Total Expenses - EUR | 12.873 | 22.594 | 27.327 | 13.133 | 4.604 | 9.721 | 12.479 | 6.440 | 72 | 1.525 |
| Gross Profit/Loss - EUR | 19.524 | 13.087 | 15.477 | 5.246 | -4.604 | 3.236 | 5.336 | -1.168 | -72 | 6.520 |
| Net Profit/Loss - EUR | 18.552 | 12.731 | 15.059 | 5.062 | -4.604 | 3.106 | 5.180 | -1.220 | -72 | 5.498 |
| Employees | 2 | 3 | 3 | 3 | 1 | 1 | 1 | 1 | 0 | 0 |
Check the financial reports for the company - Deraclin Grup Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 7.049 | 4.744 | 2.679 | 526 | 0 | 0 | 0 | 0 |
| Current Assets | 19.947 | 14.636 | 16.112 | 3.536 | 330 | 6.102 | 11.287 | 9.620 | 9.359 | 10.640 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 11.371 | 13.410 | 15.516 | 3.164 | 120 | 118 | 116 | 116 | 116 | 115 |
| Cash | 8.576 | 1.226 | 596 | 372 | 209 | 5.984 | 11.171 | 9.504 | 9.244 | 10.526 |
| Shareholders Funds | 18.375 | 12.784 | 22.373 | 7.647 | 2.895 | 5.947 | 11.176 | 9.991 | 9.888 | 9.693 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 1.572 | 1.852 | 788 | 632 | 113 | 681 | 111 | -370 | -529 | 948 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "5510 - 5510" | |||||||||
| CAEN Financial Year |
5510
|
|||||||||
Comments - Deraclin Grup Srl